Checkpoint Therapeutics I...

NASDAQ: CKPT · Real-Time Price · USD
4.26
0.00 (0.00%)
At close: May 29, 2025, 3:59 PM

Checkpoint Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
41K 103K 192K 268K
Cost of Revenue
n/a 43.57M 49.83M 48.45M
Gross Profit
41K -43.46M -49.63M -48.19M
Operating Income
-56.17M -52.15M -58.33M -56.72M
Interest Income
11K 84K 160K 53K
Pretax Income
-56.24M -51.85M -62.62M -56.67M
Net Income
-56.24M -51.85M -66.92M -56.62M
Selling & General & Admin
20.06M 8.69M 8.7M 8.54M
Research & Development
36.15M 43.57M 49.83M 48.45M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
56.22M 52.25M 58.52M 56.99M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 400K n/a
Cost & Expenses
56.22M 52.25M 58.52M 56.99M
Income Tax Expense
n/a n/a 4.29M -53K
Shares Outstanding (Basic)
39.67M 18.74M 8.84M 7.6M
Shares Outstanding (Diluted)
39.67M 18.74M 8.84M 7.6M
EPS (Basic)
-1.42 -2.77 -7.57 -7.45
EPS (Diluted)
-1.42 -2.77 -7.57 -7.45
EBITDA
-56.17M -52.15M -58.33M -56.72M
EBIT
-56.17M -52.15M -58.33M -56.72M
Depreciation & Amortization
n/a n/a 4.45M 236.56K